---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-018317"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-05-26T12:00:24+00:00"
generated_at: "2026-05-26T12:10:11.891860+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Moleculin posts corporate presentation on website; no new material details disclosed

## Summary
- Presentation dated May 2026 made available on company website.
- No financial results, clinical updates, or guidance provided in the filing.
- Presentation content is an image exhibit; no specific data extracted.
- This is a routine disclosure; no material changes to company outlook.

## SEC filing metadata
- accession: 0001437749-26-018317
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-05-26T12:00:24+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926018317/0001437749-26-018317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926018317/mbrx20260522c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-018317
- JSON: https://secwatch.observer/filing/0001437749-26-018317.json
- Plain text: https://secwatch.observer/filing/0001437749-26-018317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.